Literature DB >> 22562631

Esterase profile of O-phosphorylated ethyltrifluorolactates in prediction of their therapeutic and toxic effects.

E V Rudakova1, G F Makhaeva, T G Galenko, A Yu Aksinenko, V B Sokolov, R J Richardson, I V Martynov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562631     DOI: 10.1134/S1607672912020068

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  8 in total

1.  Esterase profile and analysis of structure-inhibitor selectivity relationships for homologous phosphorylated 1-hydroperfluoroisopropanols.

Authors:  G F Makhaeva; O G Serebryakova; N P Boltneva; T G Galenko; A Yu Aksinenko; V B Sokolov; I V Martynov
Journal:  Dokl Biochem Biophys       Date:  2008 Nov-Dec       Impact factor: 0.788

2.  Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.

Authors:  Nigel H Greig; Tadanobu Utsuki; Donald K Ingram; Yue Wang; Giancarlo Pepeu; Carla Scali; Qian-Sheng Yu; Jacek Mamczarz; Harold W Holloway; Tony Giordano; DeMao Chen; Katsutoshi Furukawa; Kumar Sambamurti; Arnold Brossi; Debomoy K Lahiri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

3.  A stable preparation of hen brain neuropathy target esterase for rapid biochemical assessment of neurotoxic potential of organophosphates.

Authors:  G F Makhaeva; V V Malygin
Journal:  Chem Biol Interact       Date:  1999-05-14       Impact factor: 5.192

4.  Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.

Authors:  Galina F Makhaeva; Alexey Y Aksinenko; Vladimir B Sokolov; Olga G Serebryakova; Rudy J Richardson
Journal:  Bioorg Med Chem Lett       Date:  2009-08-21       Impact factor: 2.823

5.  Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates.

Authors:  Vladimir V Malygin; Vladimir B Sokolov; Rudy J Richardson; Galina F Makhaeva
Journal:  J Toxicol Environ Health A       Date:  2003-04-11

6.  [Interaction of dialkyl(alpha-carbomethoxy-beta,beta,beta-trifluoro- ethyl) phosphates with mammalian esterases].

Authors:  G F Makhaeva; V I Fetisov; V B Sokolov; V L Iankovskaia; T V Goreva
Journal:  Bioorg Khim       Date:  1987-01

7.  Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.

Authors:  G F Makhaeva; I V Filonenko; V L Yankovskaya; S B Fomicheva; V V Malygin
Journal:  Neurotoxicology       Date:  1998 Aug-Oct       Impact factor: 4.294

Review 8.  Cholinesterase inhibitors: new roles and therapeutic alternatives.

Authors:  Ezio Giacobini
Journal:  Pharmacol Res       Date:  2004-10       Impact factor: 7.658

  8 in total
  1 in total

1.  N,N-disubstituted 2-aminothiazolines as new inhibitors of serine esterases.

Authors:  N P Boltneva; O G Serebryakova; G F Makhaeva; I V Serkov; A N Proshin; S O Bachurin
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.